Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel
Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel: A Randomized Controlled Trial From a Tertiary Care Centre in Pakistan
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Services Institute of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 20-70 years.
- Diagnosis of gallstone disease confined to the gallbladder.
- Scheduled for elective laparoscopic cholecystectomy.
Exclusion Criteria:
- ASA (American Society of Anesthesiologists) physical status class III or IV.
- Renal dysfunction (serum creatinine > 2.0 mg/dL).
- Coagulopathy (PT >1 s above control, aPTT >33 s, INR >1.5).
- Pregnancy.
- Presence of common bile duct stones.
- Previous upper abdominal surgery or laparotomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Clipless Harmonic Scalpel Cholecystectomy
Patients in this arm undergo a clipless laparoscopic cholecystectomy using a harmonic scalpel.
Dissection of Calot's triangle is performed with the harmonic scalpel.
The cystic duct and cystic artery are occluded and divided using the harmonic shear without the application of any metal clips.
The harmonic scalpel is used on power setting 2 for closure and division of the cystic pedicle.
The gallbladder is dissected from the liver bed using the harmonic scalpel on power setting 5 to achieve hemostasis.
An abdominal drain is placed in Morrison's pouch at the end of the procedure according to unit protocol.
|
Patients in this arm undergo a clipless laparoscopic cholecystectomy using a harmonic scalpel.
Dissection of Calot's triangle is performed with the harmonic scalpel.
The cystic duct and cystic artery are occluded and divided using the harmonic shear without the application of any metal clips.
The harmonic scalpel is used on power setting 2 for closure and division of the cystic pedicle.
The gallbladder is dissected from the liver bed using the harmonic scalpel on power setting 5 to achieve hemostasis.
|
|
Active Comparator: Conventional Clip-Based Cholecystectomy
Patients in this arm undergo a conventional laparoscopic cholecystectomy.
Calot's triangle is dissected using standard instruments and monopolar electrocautery.
The cystic duct and cystic artery are individually controlled with metal clips (two clips applied proximally toward the common bile duct / hepatic artery side and one clip distally on the specimen side) and divided with laparoscopic scissors.
The gallbladder is dissected from the liver bed using a monopolar hook.
An abdominal drain is placed in Morrison's pouch at the end of the procedure according to unit protocol.
|
Patients in this arm undergo a conventional laparoscopic cholecystectomy.
Calot's triangle is dissected using standard instruments and monopolar electrocautery.
The cystic duct and cystic artery are individually controlled with metal clips (two clips applied proximally toward the common bile duct / hepatic artery side and one clip distally on the specimen side) and divided with laparoscopic scissors.
The gallbladder is dissected from the liver bed using a monopolar hook
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative Time in minutes
Time Frame: 120 minutes
|
Defined as the time from skin incision to the completion of skin closure, measured in minutes.
|
120 minutes
|
|
Intraoperative Blood Loss in ml
Time Frame: 120 minutes
|
Defined as the total volume of blood collected in suction canisters after subtracting the volume of irrigation fluid used, measured in milliliters.
|
120 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of Postoperative Hospital Stay in days
Time Frame: 6 days
|
Defined as the number of days from operation to discharge when the patient can tolerate oral intake and pain is well-controlled with oral medication.
|
6 days
|
|
Port-Site Infection Rate
Time Frame: 7-10 days
|
Defined as the presence of fever (>100°F) with pain and purulent discharge from any port site.
|
7-10 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Awais Amjad, MBBS, FCPS, Services Institute of Medical Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RCT24SIMS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.